TITLE

Gynaecomastia associated with saquinavir therapy

AUTHOR(S)
Donovan, Basil; Bodsworth, Neil J.; Mulhall, Brian P.; Allen, Debbie; Donovan, B; Bodsworth, N J; Mulhall, B P; Allen, D
PUB. DATE
January 1999
SOURCE
International Journal of STD & AIDS;Jan1999, Vol. 10 Issue 1, p49
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Gynaecomastia has been reported in an HIV-1- infected man treated with a triple antiviral regimen including indinavir1. We describe 4 cases of men with gynaecomastia associated with saquinavir (hard gel capsule) therapy who denied taking any hormonal supplements or opiates.
ACCESSION #
22202329

 

Related Articles

  • Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. Carriquiry, Gabriela; Fink, Valeria; Koethe, John Robert; Giganti, Mark Joseph; Jayathilake, Karu; Blevins, Meridith; Cahn, Pedro; Grinsztejn, Beatriz; Wolff, Marcelo; Pape, Jean William; Padgett, Denis; Madero, Juan Sierra; Gotuzzo, Eduardo; McGowan, Catherine Carey; Shepherd, Bryan Earl // Journal of the International AIDS Society;2015, Vol. 18 Issue 1, p1 

    Introduction: Long-term survival of HIV patients after initiating highly active antiretroviral therapy (ART) has not been sufficiently described in Latin America and the Caribbean, as compared to other regions. The aim of this study was to describe the incidence of mortality, loss to follow-up...

  • HIV-1 protease-induced apoptosis. Rumlová, Michaela; Křížová, Ivana; Keprová, Alena; Hadravová, Romana; Doležal, Michal; Strohalmová, Karolína; Pichová, Iva; Hájek, Miroslav; Ruml, Tomáš // Retrovirology;2014, Vol. 11 Issue 1, p1 

    Background Apoptosis is one of the presumptive causes of CD4+ T cell depletion during HIV infection and progression to AIDS. However, the precise role of HIV-1 in this process remains unexplained. HIV-1 protease (PR) has been suggested as a possible factor, but a direct link between HIV-1 PR...

  • Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients. Charbit, B.; Gayat, E.; Voiriot, P.; Boccara, F.; Girard, P.-M.; Funck-Brentano, C. // Clinical Pharmacology & Therapeutics;Sep2011, Vol. 90 Issue 3, p442 

    We examined the prevalence and the extent of prolongation of the PR and QRS intervals and their relation to anti-HIV treatments and other clinical characteristics in 970 HIV-infected patients, 749 treated with antiretroviral therapy and 221 untreated. Age, body mass index, heart rate, and...

  • Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients. Santos, Lívia O.; Vitório, Bianca S.; Branquinha, Marta H.; Pedroso e Silva, Conceição M.; Santos, André L. S.; d'Avila-Levy, Claudia M. // Journal of Antimicrobial Chemotherapy (JAC);Feb2013, Vol. 68 Issue 2, p348 

    Objectives There is a general lack of effective and non-toxic chemotherapeutic agents for leishmaniasis and there is as yet no study about the effect of HIV peptidase inhibitors (HIV PIs) on Leishmania/HIV-coinfected patients. In the present work, we performed a comparative analysis of the...

  • HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 "Aging" Study. Perrin, Sophie; Cremer, Jonathan; Faucher, Olivia; Reynes, Jacques; Dellamonica, Pierre; Micallef, Joëlle; Solas, Caroline; Lacarelle, Bruno; Stretti, Charlotte; Kaspi, Elise; Robaglia-Schlupp, Andreé; Tamalet, Corine Nicolino-Brunet Catherine; Lévy, Nicolas; Poizot-Martin, Isabelle; Cau, Pierre; Roll, Patrice // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Background: The ANRS EP45 ''Aging'' study investigates the cellular mechanisms involved in the accelerated aging of HIV-1 infected and treated patients. The present report focuses on lamin A processing, a pathway known to be altered in systemic genetic progeroid syndromes. Methods: 35 HIV-1...

  • Gynaecomastia in a male patient during stavudine and didanosine treatment for HIV infection. Aquilina, C.; Viraben, R. // International Journal of STD & AIDS;Jul2001, Vol. 12 Issue 7, p481 

    We report a case of gynaecomastia developed in a HIV-seropositive man, associated with a severe lipodystrophy. We hypothesize the responsibility of stavudine and didanosine in the development of these 2 complications. If many reports suggest that the protease inhibitors may promote...

  • Saquinavir.  // AHFS Consumer Medication Information;Jun2020, p1 

    Saquinavir is used in combination with ritonavir (Norvir) and other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency syndrome (AIDS). Saquinavir is in a class of antiviral medications called protease inhibitors. It works by...

  • New drugs for treating drug resistant HIV-1. Isaac, A.; Pillay, D. // Sexually Transmitted Infections;Jun2003, Vol. 79 Issue 3, p176 

    Provides information on drugs for treating drug resistant HIV-1. Nucleoside/nucleotide analogues; Non-nucleoside reverse transcriptase inhibitors; Protease inhibitors; Fusion inhibitors.

  • Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy. Vergis, Emanuel N.; Paterson, David L.; Wagener, Marilyn M.; Swindells, Susan; Singh, Nina; Vergis, E N; Paterson, D L; Wagener, M M; Swindells, S; Singh, N // International Journal of STD & AIDS;Jul2001, Vol. 12 Issue 7, p463 

    Metabolic complications are being increasingly recognized among HIV-infected patients treated with potent combination antiretroviral therapies. We sought to assess the association of dyslipidaemia with adherence to protease inhibitor (PI) therapy and with the markers of clinical response to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics